At a glance
ClinicalIndex Comparison RecordN/ACompleted· 12,000 enrolled
Drug / intervention
Antithromboticsdrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
A Prospective Evaluation of Bleeding Risk of Anticoagulant and Antiplatelet Therapy for Interventional Techniques
In Brief
An observational study evaluating Antithrombotics for Bleeding. Completed, enrolled 12,000 participants across 1 site.
Detailed Summary
This study will evaluate bleeding risk and differences in outcomes in patients receiving and not receiving anticoagulant or antiplatelet therapy
Study Details
Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsBleeding
CountriesUnited States
Collaborators--
Timeline
N/ACompletedFinished
20082009201020112012201320142015201620172018201920202021202220232024202520262027
Enrollment StartFeb 2008
First PostedFeb 2008
Primary CompletionJan 2009
Study CompletionJan 2010
TodayJul 2026
First PostedFeb 28, 2008
Enrollment StartFeb 1, 2008
Primary CompletionJan 1, 2009
Study CompletionJan 1, 2010
TodayJul 2, 2026
Enrollment to primary: 11 monthsPosted 18.3 years ago
Interventions
Antithromboticsdrug
With or without or discontinuted use of Antithrombotics